tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market
NTLA
Intellia Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Intellia Therapeutics (NTLA) Stock News & Sentiment

Compare
3,651 Followers
Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Market Game-Changer?
Premium
Company Announcements
Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Market Game-Changer?
4d ago
NTLA
REGN
Regeneron and Intellia’s Gene Therapy Study: A Potential Game-Changer for Hemophilia B
Premium
Company Announcements
Regeneron and Intellia’s Gene Therapy Study: A Potential Game-Changer for Hemophilia B
6d ago
NTLA
REGN
Insider Sales Shake Royal Caribbean, Kroger, HP, Intellia, EOG
Premium
Weekend Updates
Insider Sales Shake Royal Caribbean, Kroger, HP, Intellia, EOG
17d ago
KR
EOG
Promising Phase 1 Results and High Interest in Phase 3 Trial Boost Buy Rating for Intellia Therapeutics
Premium
Ratings
Promising Phase 1 Results and High Interest in Phase 3 Trial Boost Buy Rating for Intellia Therapeutics
1M ago
NTLA
Intellia Therapeutics Announces Positive Phase 1 Trial Data
Premium
Company Announcements
Intellia Therapeutics Announces Positive Phase 1 Trial Data
1M ago
8K
NTLA
Intellia Therapeutics’ Lonvo-z Shows Promising Efficacy and Safety, Supporting Buy Rating
Premium
Ratings
Intellia Therapeutics’ Lonvo-z Shows Promising Efficacy and Safety, Supporting Buy Rating
1M ago
NTLA
Intellia Therapeutics’ NTLA-2002 Shows Promising Efficacy and Safety in HAE Treatment, Supporting Buy Rating
Premium
Ratings
Intellia Therapeutics’ NTLA-2002 Shows Promising Efficacy and Safety in HAE Treatment, Supporting Buy Rating
1M ago
NTLA
More NTLA News >

NTLA News on the Web

Why Intellia Therapeutics, Inc.’s (NTLA) Stock Is Up 8.87%
AAII
Neutral
Why Intellia Therapeutics, Inc.’s (NTLA) Stock Is Up 5.15%
AAII
Neutral
Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
MarketBeat
Neutral
Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus
Zacks
Neutral
Why Intellia Therapeutics, Inc.’s (NTLA) Stock Is Up 9.35%
AAII
Neutral
Why Intellia Therapeutics, Inc.’s (NTLA) Stock Is Up 6.54%
AAII
Neutral
Intellia Therapeutics (NTLA) Receives a Buy from RBC Capital
TipRanks News
Neutral
Intellia Gains 29.8% in a Month: How Should You Play the Stock?
Zacks
Neutral

News Score - Last 7 Days

Neutral
NTLA
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.5 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NTLA’s Media Buzz Sentiment?
3 articles about NTLA were published this week. In an average week, 3.5 articles are published.
    What is NTLA’s weekly average amount of articles?
    In an average week, 3.5 articles about NTLA are published.
      What is NTLA’s News Sentiment?
      50% of articles about NTLA were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        JNJJohnson & Johnson
        SRPTSarepta Therapeutics
        ABTAbbott Laboratories
        GMEDGlobus Medical
        ELVElevance Health
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing